Cargando…
Antisense inhibition of ATM gene enhances the radiosensitivity of head and neck squamous cell carcinoma in mice
BACKGROUND: Treatment failure after radiotherapy of head and neck squamous cell carcinoma (HNSCC) could be a significant problem. Our objective is to sensitize SCCVII cells to ionizing radiation in vitro and in vivo through inhibiting ATM expression using antisense oligodeoxynucleotides (AS-ODNs), a...
Autores principales: | Zou, Jian, Qiao, Xiaoming, Ye, Huiping, Yang, Yuqiong, Zheng, Xuelian, Zhao, Houyu, Liu, Shixi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584003/ https://www.ncbi.nlm.nih.gov/pubmed/18950535 http://dx.doi.org/10.1186/1756-9966-27-56 |
Ejemplares similares
-
Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice
por: Feng, Jun, et al.
Publicado: (2011) -
Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2021) -
Integrating Intrinsic Radiosensitivity and Immune Status for Predicting Benefits of Radiotherapy in Head and Neck Squamous Cell Carcinoma
por: Sun, Chuyao, et al.
Publicado: (2021) -
MiR-125 family improves the radiosensitivity of head and neck squamous cell carcinoma
por: Wang, Qi-Wei, et al.
Publicado: (2023) -
Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)